Review paper

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics

Volume: 19, Issue: 5, Pages: 614 - 624
Published: Feb 21, 2017
Abstract
The 2007 World Health Organization (WHO) classification of brain tumors did not use molecular abnormalities as diagnostic criteria. Studies have shown that genotyping allows a better prognostic classification of diffuse glioma with improved treatment selection. This has resulted in a major revision of the WHO classification, which is now for adult diffuse glioma centered around isocitrate dehydrogenase (IDH) and 1p/19q diagnostics. This revised...
Paper Details
Title
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics
Published Date
Feb 21, 2017
Volume
19
Issue
5
Pages
614 - 624
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.